Respiratory Flashcards
Management of idiopathic pulmonary fibrosis
Pulmonary rehabilitation
Pirfenidone (an antifibrotic agent)
Nintedanib
Antidote for cyanide poisoning.
Hydroxocobalamin
Benzodiazepine overdose - treatment
Flumazenil
Theophylline - use
Bronchodilator in the management of asthma and COPD
BTS guidelines for lung nodules:
Nodule <5mm
Can be discharged
BTS guidelines for lung nodules:
Nodule 5-6mm, or =>8mm and low-risk
CT surveillance
BTS guidelines for lung nodules:
Nodule =>8mm and high risk
CT-PET, and if CT-PET shows high uptake then biopsy
Allergic bronchopulmonary aspergillosis - define + management
Allergy to Aspergillus spores
Oral glucocorticoids
Itraconazole is sometimes introduced as a second-line agent
Histoplasmosis - define + treatment
Fungus Histoplasma capsulatum
Amphotericin or Itraconazole
Extrinsic allergic alveolitis - define
Hypersensitivity induced lung damage due to a variety of inhaled organic particles
Immune-complex mediated tissue damage (type III hypersensitivity) although delayed hypersensitivity (type IV) is also thought to play a role in EAA, especially in the chronic phase.
Most common infective causes of COPD exacerbations
Haemophilus influenzae (most common cause)
Streptococcus pneumoniae
Moraxella catarrhalis
Pulmonary hypertension - define
Sustained elevation in mean pulmonary arterial pressure of greater than 20 mmHg at rest
FEV1/FVC ratio < 0.7
Obstructive lung disease
COPD - still breathless despite using SABA/SAMA and a LABA + ICS
Add a LAMA
Tiotropium is a long-acting muscarinic antagonist (LAMA)
Microscopic polyangiitis
Small-vessel ANCA vasculitis.
Typically positive for p-ANCA, with antibodies against MPO (myeloperoxidase)
Mononeuritis multiplex
Exudates have a protein level of
> 30 g/L
Transudates have a protein level of
<30 g/L
Lung cancer is histologically subdivided as:
Non-small cell carcinoma (NSCLC) - (squamous cell carcinoma, adenocarcinoma, and large cell carcinoma)
Small cell carcinoma (SCLC)
Eosinophilic granulomatosis with polyangiitis - define
Churg-Strauss syndrome
ANCA associated small-medium vessel vasculitis.
Eosinophilic granulomatosis with polyangiitis - features
Churg-Strauss syndrome
Asthma
Blood eosinophilia (e.g. > 10%)
Mononeuritis multiplex
Renal involvement
pANCA positive in 60%
Small cell cancer - paraneoplastic features
ADH
ACTH - hypertension, hyperglycaemia, hypokalaemia, alkalosis and muscle weakness
Lambert-Eaton syndrome
Squamous cell - paraneoplastic features
Parathyroid hormone-related protein (PTH-rp) secretion
Clubbing
Hypertrophic pulmonary osteoarthropathy (HPOA)
Hyperthyroidism due to ectopic TSH
Smokers -> liver enzyme inhibitor or inducer?
Inducer
Omalizumab - MOA
Anti-IgE monoclonal antibody
Severe allergic asthma
Etanercept - MOA
Anti-TNF antibodies
Rheumatoid arthritis
Acute respiratory distress syndrome (ARDS) - define
Increased permeability of alveolar capillaries leading to fluid accumulation in the alveoli.
i.e. non-cardiogenic pulmonary oedema
Obstructive - Spirometry
FEV1/FVC < 80%
Obstructive - Examples
COPD:
Chronic bronchitis
Emphysema: including alpha-1 antitrypsin deficiency
Asthma
Bronchiectasis
Restrictive - Spirometry
FEV1/FVC > 80%
Restrictive - Examples
Idiopathic pulmonary fibrosis
Sarcoidosis
Histiocytosis
Drug-induced fibrosis: amiodarone, bleomycin, methotrexate
Asbestosis
Obesity
Scoliosis
Granulomatosis with polyangiitis
Wegener’s granulomatosis
Renal Failure
Epistaxis / Haemoptysis
cANCA
Sinusitis, nasal crusting and pulmonary haemorrhage
Exudates have a protein level of
> 30 g/L
Treatment of histoplasmosis
Amphotericin or itraconazole
Commonly encountered in the Mississippi and Ohio River valleys
Management of Granulomatosis with polyangiitis
Steroids
Cyclophosphamide (90% response)
Plasma exchange
Treatment of choice for allergic bronchopulmonary aspergillosis
Oral Glucocorticoids
Oral Itraconazole (2nd line)
Allergic bronchopulmonary aspergillosis (ABPA) - define
Hypersensitivity reaction to the fungus Aspergillus causing an eosinophilic pneumonia
Salmeterol
LABA
Long-acting Beta Agonist
Treatment of cystic fibrosis patients who are homozygous for the delta F508 mutation
Lumacaftor/Ivacaftor (Orkambi)
? increases susceptibility to tuberculosis
Silicosis
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
Antibody?
pANCA positive in 60%
Drug to prevent acute mountain sickness
Acetazolamide (carbonic anhydrase inhibitor)
Management of HACE
Descent
Dexamethasone
Management of HAPE
Descent
Nifedipine
Dexamethasone
Acetazolamide,
Phosphodiesterase type V inhibitors
Oxygen if available
? is recommended in COPD where there are >=2 exacerbations per year and FEV1<50%
Roflumilast - Oral PDE-4 inhibitors
Causes of lower zone fibrosis
MAID
Most connective tissue diseases (e.g. rheumatoid arthritis)
Asbestosis
Idiopathic pulmonary fibrosis, infection
Drugs (e.g. methotrexate, amiodarone, bleomycin)
What drug can precipitate Eosinophilic granulomatosis with polyangiitis
Leukotriene receptor antagonists
Churg-Strauss syndrome
Causes of upper zone fibrosis:
CHARTS
C - Coal worker’s pneumoconiosis
H - Histiocytosis/ hypersensitivity pneumonitis
A - Ankylosing spondylitis
R - Radiation
T - Tuberculosis
S - Silicosis/sarcoidosis
Indications for corticosteroid treatment for sarcoidosis
Parenchymal lung disease
Uveitis
Hypercalcaemia
Neurological or cardiac involvement
How many lobes does the right lung have?
3
PR3
c-ANCA
MPO
p-ANCA
Lung Nodule 5-6mm
Nodule >6mm
CT at 1 year
CT in 3 months
Treatment for MERS
Supportive